Celgene Corp (NASDAQ:CELG)

132.56
Delayed Data
As of Jul 27
 -2.34 / -1.73%
Today’s Change
83.16
Today|||52-Week Range
140.72
+18.51%
Year-to-Date

Today’s Trading

Previous close134.90
Today’s open133.45
Day’s range131.11 - 133.45
Volume6,791,345
Average volume (3 months)4,838,924
Market cap$107.0B
Dividend yield--
Data as of 4:14pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.27%
Earnings growth (next 5 years)+24.56%
Revenue growth (last year)+17.89%
P/E ratio45.3
Price/Sales12.24
Price/Book16.54

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+1.26+1.85%
BMYBristol-Myers Squibb-1.68-2.55%
GSKGlaxoSmithKline+0.21+0.51%
NVONovo Nordisk-0.18-0.31%
Data as of 4:03pm ET, 07/27/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers